Via Wired, Allen Frances, chairman of the task force behind the previous edition of psychiatrists’ widely-used Diagnostic and Statistical Manual, is vocally critical of the new DSM, arguing that it is part of a push toward over-medication:
Nature takes the long view, mankind the short. Nature picks diversity; we pick standardization. We are homogenizing our crops and homogenizing our people. And Big Pharma seems intent on pursuing a parallel attempt to create its own brand of human monoculture.
With an assist from an overly ambitious psychiatry, all human difference is being transmuted into chemical imbalance meant to be treated with a handy pill. Turning difference into illness was among the great strokes of marketing genius accomplished in our time.
Human diversity has its purposes or it would not have survived the evolutionary rat race. Human difference was never meant to be reducible to an exhaustive list of diagnoses drawn carelessly from a psychiatric manual.









